XML 71 R55.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details 3) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Employee Stock Purchase Plan
       
Assumptions used in determining the fair value of the stock-based awards        
Risk-free interest rate (as a percent) 0.10% 0.10% 0.10% 0.10%
Expected Volatility, (as a percent) 31.80% 31.00% 31.80% 31.00%
Expected life 6 months 6 months 6 months 6 months
Expected dividends (as a percent) 0.00% 0.00% 0.00% 0.00%
Stock Options / Stock Appreciation Rights
       
Assumptions used in determining the fair value of the stock-based awards        
Risk-free interest rate, minimum (as a percent) 0.50% 0.60% 0.50% 0.60%
Risk-free interest rate, maximum (as a percent) 1.00% 1.00% 1.00% 1.20%
Volatility, minimum (as a percent) 33.40% 38.40% 33.40% 38.40%
Volatility, maximum (as a percent) 38.50% 39.70% 38.80% 42.60%
Expected dividends (as a percent) 0.00% 0.00% 0.00% 0.00%
Number of Shares        
Outstanding at beginning of year (in shares)     7,668  
Options and SARs granted (in shares)     1,152  
Options and SARs exercised (in shares)     (2,050)  
Options and SARs canceled (in shares)     (220)  
Outstanding at end of period (in shares) 6,550   6,550  
Exercisable at end of period (in shares) 3,215   3,215  
Weighted Average Exercise Price        
Outstanding at beginning of year (in dollars per share)     $ 19.82  
Options and SARs granted (in dollars per share) $ 30.49   $ 30.49  
Options and SARs exercised (in dollars per share) $ 15.71   $ 15.71  
Options and SARs canceled (in dollars per share) $ 25.51   $ 25.51  
Outstanding at end of period (in dollars per share) $ 22.79   $ 22.79  
Exercisable at end of period (in dollars per share) $ 18.74   $ 18.74  
Weighted average remaining contractual life of options and SARs outstanding, at end of period     11 days  
Weighted average remaining contractual life of options and SARs exercisable, at end of period     11 days  
Aggregate intrinsic value of options and SARs outstanding $ 80,371   $ 80,371  
Aggregate intrinsic value of options and SARs exercisable 52,460   52,460  
Additional disclosure about options and SARs        
Closing price of stock (in dollars per share) $ 35.06   $ 35.06  
Weighted average grant date fair value (in dollars per share) $ 10.45 $ 9.38 $ 10.45 $ 9.38
Total intrinsic value of awards exercised     26,518 6,578
Stock Options / Stock Appreciation Rights | Maximum
       
Assumptions used in determining the fair value of the stock-based awards        
Expected life 5 years 22 days 5 years 1 month 20 days 5 years 22 days 5 years 1 month 20 days
Stock Options / Stock Appreciation Rights | Minimum
       
Assumptions used in determining the fair value of the stock-based awards        
Expected life 3 years 11 months 8 days 4 years 7 days 3 years 11 months 8 days 4 years 7 days
Options
       
Additional disclosure about options and SARs        
Cash received from exercises     $ 16,212 $ 3,269